Literature DB >> 14688488

Hypertension in the metabolic syndrome and diabetes: pathogenesis, clinical studies, and treatment.

Joseph L Izzo1.   

Abstract

The increasing prevalence of obesity, hypertension, and abnormal glucose metabolism is a major challenge to health care in industrialized societies. This brief review summarizes the mechanistic evidence and clinical studies related to the problem of hypertension in the metabolic syndrome and diabetes to allow clinicians to provide more effective and enlightened management of these common, interrelated problems.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14688488      PMCID: PMC8099212          DOI: 10.1111/j.1524-6175.2003.02670.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  74 in total

1.  Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study.

Authors:  M Pyörälä; H Miettinen; M Laakso; K Pyörälä
Journal:  Diabetes Care       Date:  2000-08       Impact factor: 19.112

2.  Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies.

Authors:  James B Meigs; Peter W F Wilson; David M Nathan; Ralph B D'Agostino; Ken Williams; Steven M Haffner
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

Review 3.  Obesity and hypertension. Hemodynamic aspects.

Authors:  E D Frohlich
Journal:  Ann Epidemiol       Date:  1991-05       Impact factor: 3.797

4.  Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods.

Authors:  Leora Henkin; Richard N Bergman; Donald W Bowden; Darrell L Ellsworth; Steven M Haffner; Carl D Langefeld; Braxton D Mitchell; Jill M Norris; Marian Rewers; Mohammed F Saad; Elizabeth Stamm; Lynne E Wagenknecht; Stephen S Rich
Journal:  Ann Epidemiol       Date:  2003-04       Impact factor: 3.797

Review 5.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

Review 6.  Obesity hypertension, salt sensitivity and insulin resistance.

Authors:  A P Rocchini
Journal:  Nutr Metab Cardiovasc Dis       Date:  2000-10       Impact factor: 4.222

7.  Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man.

Authors:  S Lillioja; A A Young; C L Culter; J L Ivy; W G Abbott; J K Zawadzki; H Yki-Järvinen; L Christin; T W Secomb; C Bogardus
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

Review 8.  The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension.

Authors:  S Julius; T Gudbrandsson; K Jamerson; O Andersson
Journal:  Blood Press       Date:  1992-05       Impact factor: 2.835

9.  Arterial and venous compliance in obese and nonobese subjects.

Authors:  S Oren; E Grossman; E D Frohlich
Journal:  Am J Cardiol       Date:  1996-03-15       Impact factor: 2.778

10.  Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The ARIC Study. Atherosclerosis Risk in Communities Study.

Authors:  V Salomaa; W Riley; J D Kark; C Nardo; A R Folsom
Journal:  Circulation       Date:  1995-03-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.